Skip to main content
SpringerLink
Log in
Book cover

Total Intravenous Anesthesia and Target Controlled Infusions pp 245–265Cite as

Clinical Effects and Applications of Ketamine

  • Chapter
  • First Online:

Abstract

Ketamine was originally developed as a potent but safe intravenous anesthetic drug which has subsequently been used for premedication, sedation, induction, and maintenance of general anesthesia (Sinner and Graf, Handb Exp Pharmacol 182:313–333, 2008). It is currently widely administered to children for dissociative sedation for painful procedures performed outside the operating room (Green et al., Ann Emerg Med 54:158–168, 2009; Green et al., Ann Emerg Med 54(2):171–80.e1–4, 2009). Due to its unique and diverse properties, a large number of additional indications for ketamine have developed since it was derived from phencyclidine in 1963. This chapter will review the history, pharmacology, clinical effects, and applications of ketamine. The evidence for and against traditional and expanding indications for ketamine administration will be examined.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   229.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Sinner B, Graf BM. Ketamine. Handb Exp Pharmacol. 2008;182:313–33.

    Article  CAS  Google Scholar 

  2. Green SM, Roback MG, Krauss B, et al. Predictors of airway and respiratory adverse events with ketamine sedation in the emergency department: an individual patient data meta-analysis of 8,282 children. Ann Emerg Med. 2009;54:158–68.

    Article  PubMed  Google Scholar 

  3. Green SM, Roback MG, Krauss B, et al. Predictors of emesis and recovery agitation with emergency department ketamine sedation: an individual-patient data meta-analysis of 8,282 children. Ann Emerg Med. 2009;54(2):171–80.e1–4.

    Google Scholar 

  4. Domino EF. Taming the ketamine tiger. 1965. Anesthesiology. 2010;113(3):678–84.

    PubMed  Google Scholar 

  5. White PF, Way WL, Trevor AJ. Ketamine-its pharmacology and therapeutic uses. Anesthesiology. 1982;56:119–36.

    Article  CAS  PubMed  Google Scholar 

  6. Wolff K, Winstock AR. Ketamine. From medicine to misuse. CNS Drugs. 2006;20(3):199–218

    Article  CAS  PubMed  Google Scholar 

  7. Sin B, Ternas T, Motov SM. The use of subdissociative-dose ketamine for acute pain in the emergency department. Acad Emerg Med. 2015;22(3):251–7.

    Google Scholar 

  8. Wiel E, Zitouni D, Assez N. Continuous infusion of ketamine for out-of-hospital isolated orthopedic injuries secondary to trauma: a randomized controlled trial. Prehosp Emerg Care. 2015;19:10–6.

    Article  PubMed  Google Scholar 

  9. Patanwala AE, McKinney CB, Erstad BL, Sakles JC. Retrospective analysis of etomidate versus ketamine for first-pass intubation success in an academic emergency department. Acad Emerg Med. 2014;21:88–91

    Article  Google Scholar 

  10. Kiureghian E, Kowalski JM. Intravenous ketamine to facilitate noninvasive ventilation in a patient with a severe asthma exacerbation. Am J Emerg Med. 2015;33:1720.e1–1720.e2.

    Article  Google Scholar 

  11. Keseg D, Cortez E, Rund D, et al. The use of prehospital ketamine for control of agitation in a metropolitan firefighter-based EMS system. Prehosp Emerg Care. 2015;19:110–5.

    Article  PubMed  Google Scholar 

  12. Feder A, Parides MK, Murrough JW, et al. Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2014;1(6):681–8.

    Article  CAS  Google Scholar 

  13. Li JH, Vicknasingam B, Cheung Y, et al. To use or not to use: an update on licit and illicit ketamine use. Subst Abuse Rehabil. 2011;2:11–20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Domino EF, Chodoff P, Corssen G. Pharmacologic effects of CI-581, a new dissociative anesthetic, in man. Clin Pharmacol Ther. 1965;6(3):279–86.

    Article  CAS  PubMed  Google Scholar 

  15. Corssen G, Domino EF. Dissociative anesthesia: further pharmacologic studies and first clinical experience with the phencyclidine derivative CI-581. Anesth Analg. 1966;45(1):29–40.

    Article  CAS  PubMed  Google Scholar 

  16. Green SM, Johnson NE. Ketamine sedation for pediatric procedures: part 2, review and implications. Ann Emerg Med. 1990;19:1033–46.

    Article  CAS  PubMed  Google Scholar 

  17. Green SM, Roback MG, Kennedy RM, et al. Clinical practice guideline for emergency department ketamine dissociative sedation in children: 2011 update. Ann Emerg Med. 2011;57:449–61.

    Article  PubMed  Google Scholar 

  18. Bhargava R, Young KD. Procedural pain management patterns in academic pediatric emergency departments. Acad Emerg Med. 2007;14(5):479–82.

    Article  PubMed  Google Scholar 

  19. Reich DL, Silvay G. Ketamine: an update on the first twenty-five years of clinical experience. Can J Anaesth. 1989;36(2):186–97.

    Article  CAS  PubMed  Google Scholar 

  20. Bergman SA. Ketamine: a review of its pharmacology and its use in pediatric anesthesia. Anesth Prog. 1999;46:10–20.

    CAS  PubMed  PubMed Central  Google Scholar 

  21. Kennedy RM. Sedation in the emergency department: a complex and multifactorial challenge. In: Mason KP, editor. Pediatric sedation outside the operating room: a multispecialty international collaboration. New York: Springer; 2015.

    Google Scholar 

  22. Ramaswamy P, Babl FE, Deasy C, et al. Pediatric procedural sedation with ketamine: time to discharge after intramuscular versus intravenous administration. Acad Emerg Med. 2009;16:101–7.

    Article  PubMed  Google Scholar 

  23. Chinta SS, Schrock CR, McAllister JD, et al. Rapid administration technique of ketamine for pediatric forearm fracture reduction: a dose-finding study. Ann Emerg Med. 2015;65(6):640–8. e2.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Sahyoun C, Krauss B. Clinical implications of pharmacokinetics and pharmacodynamics of procedural sedation agents in children. Curr Opin Pediatr. 2012;24:225–32.

    Article  CAS  PubMed  Google Scholar 

  25. Roback MG, Wathen JE, Mackenzie T, Bajaj L. A randomized, controlled trial of iv vs. im ketamine for sedation of pediatric patients receiving emergency department orthopedic procedures. Ann Emerg Med. 2006;48:605–12.

    Article  PubMed  Google Scholar 

  26. Deasy C, Babl FE. Intravenous vs intramuscular ketamine for pediatric procedural sedation by emergency medicine specialists: a review. Pediatr Anesth. 2010;20:787–96.

    Article  Google Scholar 

  27. Wolfe T. Sedation: intranasal sedatives. Available at: http://www.intranasal.net/. Accessed Jan 2016.

  28. Graudins A, Meek R, Egerton-Warburton D. The PICHFORK (pain in children fentanyl or ketamine) trial: a randomized controlled trial comparing intranasal ketamine and fentanyl for the relief of moderate to server pain in children with limb injuries. Ann Emerg Med. 2015;65(3):248–54.

    Article  PubMed  Google Scholar 

  29. Andolfatto G, Willman E, Joo D, et al. Intranasal ketamine for analgesia in the emergency department: a prospective observational series. Acad Emerg Med. 2013;20:1050–4.

    Article  PubMed  Google Scholar 

  30. Diaz JH. Intranasal ketamine preinduction of paediatric outpatients. Paediatr Anaesth. 1997;7:273–8.

    Article  CAS  PubMed  Google Scholar 

  31. Weber F, Wulf H, el Saeidi G. Premedication with nasal s-ketamine and midazolam provides good conditions for induction of anesthesia in preschool children. Can J Anaesth. 2003;50:470–5.

    Article  PubMed  Google Scholar 

  32. Tsze DS, Steele DW, Machan JT, et al. Intranasal ketamine for procedural sedation in pediatric laceration repair. Pediatr Emerg Care. 2012;28:767–70.

    Article  PubMed  Google Scholar 

  33. Barkan S, Breitbart R, Brenner-Zada G, et al. A double-blind, randomized, placebo-controlled trial of oral midazolam plus oral ketamine for sedation of children during laceration repair. Emerg Med J. 2014;31(8):649–53.

    Article  PubMed  Google Scholar 

  34. Younge PA, Kendall JM. Sedation for children requiring wound repair: a randomized controlled double blind comparison of oral midazolam and oral ketamine. Emerg Med J. 2001;18:30–3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Brown L, Christian-Kopp S, Sherwin TS, et al. Adjunctive atropine is unnecessary during ketamine sedation in children. Acad Emerg Med. 2008;15(4):314–8.

    Article  PubMed  Google Scholar 

  36. Kye YC, Rhee JE, Kim K, et al. Clinical effects of adjunctive atropine during ketamine sedation in pediatric emergency patients. Am J Emerg Med. 2012;30:1981–5.

    Article  PubMed  Google Scholar 

  37. Green SM, Roback MG, Krauss B. Anticholinergics and ketamine sedation in children: an observational analysis of atropine versus glycopyrrolate. Acad Emerg Med. 2010;17:157–62.

    Article  PubMed  Google Scholar 

  38. Flick RP, Wilder RT, Pieper SF, et al. Risk factors for laryngospasm in children during general anesthesia. Pediatr Anesth. 2008;18:289–96.

    Article  Google Scholar 

  39. Green SM, Roback MG, Krauss B. Emergency department ketamine meta-analysis study group. Laryngospasm during emergency department ketamine sedation: a case control study. Pediatr Emerg Care. 2010;26(11):798–802.

    Article  PubMed  Google Scholar 

  40. Wathen J, Roback MG, Mackenzie T, Bothner JP. Does midazolam alter the clinical effects of intravenous ketamine sedation in children- a double blind, prospective, emergency department report. Ann Emerg Med. 2000;36:579–88.

    Article  CAS  PubMed  Google Scholar 

  41. Roback MG, Wathen JE, Bajaj L, Bothner JP. Adverse events with procedural sedation and analgesia in a pediatric emergency department: a comparison of common parenteral drugs. Acad Emerg Med. 2005;12:508–13.

    Article  PubMed  Google Scholar 

  42. Green SM, Rothrock SG, Lynch EL, et al. Intramuscular ketamine for pediatric sedation in the emergency department: safety profile with 1,022 cases. Ann Emerg Med. 1998;31:688–97.

    Article  CAS  PubMed  Google Scholar 

  43. Cohen VG, Krauss B. Recurrent episodes of intractable laryngospasm during dissociative sedation with intramuscular ketamine. Pediatr Emerg Care. 2006;22(4):247–9.

    Article  PubMed  Google Scholar 

  44. Lippmann M, Karnwal A, Julka IS. Cardiovascular effects of ketamine in sick patients: should physicians be concerned? J Clin Pharmacol. 2010;50:482.

    Article  PubMed  Google Scholar 

  45. Lippmann M, Appel PL, Mok MS, Shoemaker WC. Sequential cardiorespiratory patterns of anesthetic induction with ketamine in critically ill patients. Crit Care Med. 1983;11:730–4.

    Article  CAS  PubMed  Google Scholar 

  46. L’Hommedieu CS, Arens JJ. The use of ketamine for the emergency intubation of patients with status asthmaticus. Ann Emerg Med. 1987;16(5):568–71.

    Article  PubMed  Google Scholar 

  47. Jabre P, Combes X, Lapostolle F, et al. Etomidate versus ketamine for rapid sequence intubation in acutely ill patients; a multicentre randomised controlled trial. Lancet. 2009;374:293–300.

    Article  CAS  PubMed  Google Scholar 

  48. Hamza J, Ecoffey C, Gross JB. Ventilatory response to CO2 following intravenous ketamine in children. Anesthesiology. 1989;70(3):422–5.

    Article  CAS  PubMed  Google Scholar 

  49. Corssen G, Butierrez J, Feves JG, Huber FC. Ketamine in the anesthetic management of asthmatic patients. Anesth Anal. 1972;51(4):588–94.

    Article  CAS  Google Scholar 

  50. Denmark TK, Crane HA, Brown L. Ketamine to avoid mechanical ventilation in severe pediatric asthma. J Emerg Med. 2006;30(2):163–6.

    Article  PubMed  Google Scholar 

  51. Shlamovitz GZ, Hawthorne T. Intravenous ketamine in a dissociating dose as a temporizing measure to avoid mechanical ventilation in adult patient with severe asthma exacerbation. J Emerg Med. 2011;41(5):492–4.

    Article  PubMed  Google Scholar 

  52. Allen JY, Macias CG. The efficacy of ketamine in pediatric emergency department patients who present with acute severe asthma. Ann Emerg Med. 2005;46:43–50.

    Article  PubMed  Google Scholar 

  53. Howton JC, Rose J, Duffy S, et al. Randomized, double-blind, placebo-controlled trial of intravenous ketamine in acute asthma. Ann Emerg Med. 1996;27:170–5.

    Article  CAS  PubMed  Google Scholar 

  54. Cohen L, Athaide V, Wickham ME. The effect of ketamine on intracranial and cerebral perfusion pressure and health outcomes: a systematic review. Ann Emerg Med. 2015;65:43–51.

    Article  PubMed  Google Scholar 

  55. Bar-Joseph G, Guilburd Y, Tamir A, Guilburd JN. Effectiveness of ketamine in decreasing intracranial pressure in children with intracranial hypertension. J Neurosurg Pediatr. 2009;4:40–6.

    Article  PubMed  Google Scholar 

  56. Sehdev RS, Symmons DAD, Kindl K. Ketamine for rapid sequence induction in patients with head injury in the emergency department. Emerg Med Australas. 2006;18:37–44.

    Article  PubMed  Google Scholar 

  57. Green SM, Andolfatto G, Krauss BS. Ketamine and intracranial pressure: no contraindication except hydrocephalus. Ann Emerg Med. 2015;65:52–4.

    Article  PubMed  Google Scholar 

  58. Drayna PC, Estrada C, Wang W, et al. Ketamine sedation is not associated with clinically meaningful elevation of intraocular pressure. Am J Emerg Med. 2012;30:1215–8.

    Article  PubMed  Google Scholar 

  59. Halstead SM, Deakyne SJ, Bajaj L, et al. The effect of ketamine on intraocular pressure in pediatric patients during procedural sedation. Acad Emerg Med. 2012;19:1145–50.

    Article  PubMed  Google Scholar 

  60. Motov S, Rockoff B, Cohen V, et al. Intravenous subdissociative-dose ketamine versus morphine for analgesia in the emergency department: a randomized controlled trial. Ann Emerg Med. 2015;66:222–9.

    Article  PubMed  Google Scholar 

  61. Miller JP, Schauer SG, Ganem VJ. Low-dose ketamine vs morphine for acute pain in the ED: a randomized controlled trial. Am J Emerg Med. 2015;33:402–8.

    Article  PubMed  Google Scholar 

  62. Ahern TL, Herring AA, Anderson ES, et al. The first 500: initial experience with widespread use of low-dose ketamine for acute pain management in the ED. Am J Emerg Med. 2015;33:197–201.

    Article  PubMed  Google Scholar 

  63. Corssen G, Dget S. Dissociative anesthesia for the severely burned child. Anesth Analg. 1971;50:95–102.

    CAS  PubMed  Google Scholar 

  64. Phillips LA, Seruvatu SG, Rika PN. Anaesthesia for the surgeon-anaesthetist in difficult situations. Anaesthesia. 1970;25:36–45.

    Article  CAS  PubMed  Google Scholar 

  65. Walker AK. Intramuscular ketamine in a developing country. Anaesthesia. 1972;27:408–14.

    Article  CAS  PubMed  Google Scholar 

  66. Trouwborst A, Weber BK, Dufour D. Medical statistics of battlefield casualties. Injury. 1987;18:96–9.

    Article  CAS  PubMed  Google Scholar 

  67. White PF. Use of continuous infusion versus intermittent bolus administration of fentanyl or ketamine during outpatient anesthesia. Anesthesiology. 1983;59:294–300.

    Article  CAS  PubMed  Google Scholar 

  68. Cravero J, Blike GT, Beach ML, et al. Incidence and nature of adverse events during pediatric sedation/anesthesia for procedures outside the operating room: a report from the Pediatric Sedation Research Consortium. Pediatrics. 2006;118:1087–96.

    Article  PubMed  Google Scholar 

  69. Kennedy RM, Porter FL, Miller P, et al. Comparison of fentanyl/midazolam with ketamine/midazolam for pediatric orthopedic emergencies. Pediatrics. 1998;102(4):956–63.

    Article  CAS  PubMed  Google Scholar 

  70. McQueen A, Wright RO, Kido MM, et al. Procedural sedation and analgesia outcomes in children after discharge from the emergency department: ketamine versus fentanyl/midazolam. Ann Emerg Med. 2009;54:191–7.

    Article  PubMed  Google Scholar 

  71. Miner JR, Burton JH. Clinical practice advisory: emergency department procedural sedation with propofol. Ann Emerg Med. 2007;50:182–7.

    Article  PubMed  Google Scholar 

  72. Cravero J, Beach ML, Blike GT, et al. The incidence and nature of adverse events during pediatric sedation/anesthesia with propofol for procedures outside the operating room: a report from the Pediatric Sedation Research Consortium. Anesth Analg. 2009;108(3):795–804.

    Article  CAS  PubMed  Google Scholar 

  73. Vespasiano M, Finkelstein M, Kurachek S. Propofol sedation: intensivists’ experience with 7304 cases in a children’s hospital. Pediatrics. 2007;120:e1411–7.

    Article  PubMed  Google Scholar 

  74. Kamat PP, McCracken CE, Gillespie SE, et al. Pediatric critical care physician-administered procedural sedation using propofol: a report from the pediatric sedation research consortium database. Pediatr Crit Care Med. 2015;16(1):11–20.

    Article  PubMed  Google Scholar 

  75. Godambe SA, Elliot V, Matheny D, et al. Comparison of propofol/fentanyl vs. ketamine/midazolam for brief orthopedic procedural sedation in a pediatric emergency department. Pediatrics. 2003;112:116–23.

    Article  PubMed  Google Scholar 

  76. Uri O, Behrbalk E, Haim A, et al. Procedural sedation with propofol for painful orthopaedic manipulation in the emergency department expedites patient management compared with a midazolam/ketamine regimen. A randomized prospective study. J Bone Joint Surg Am. 2011;93:2255–62.

    Article  PubMed  Google Scholar 

  77. Gottschling S, Meyer S, Krenn T, et al. Propofol versus midazolam/ketamine for procedural sedation in pediatric oncology. J Pediatr Hematol Oncol. 2005;27:471–6.

    Article  PubMed  Google Scholar 

  78. Green SM, Andolfatto G, Krauss B. Ketofol for procedural sedation? Pro and con. Ann Emerg Med. 2011;57:444–8.

    Article  PubMed  Google Scholar 

  79. Willman EV, Andolfatto G. A prospective evaluation of “ketofol” (ketamine/propofol combination) for procedural sedation and analgesia in the emergency department. Ann Emerg Med. 2007;49(1):23–30. Epub 2006 Oct 23.

    Article  PubMed  Google Scholar 

  80. Sharieff GQ, Trocinski DR, Kanegaye JT, et al. Ketamine-propofol combination sedation for fracture reduction in the pediatric emergency department. Pediatr Emerg Care. 2007;23(12):881–4.

    Article  PubMed  Google Scholar 

  81. Andolfatto G, Willman E. A prospective case series of pediatric procedural sedation and analgesia in the emergency department using single-syringe ketamine-propofol combination (ketofol). Acad Emerg Med. 2010;17:194–201.

    Article  PubMed  Google Scholar 

  82. Andolfatto G, Willman E. A prospective case series of single-syringe ketamine-propofol combination (ketofol) for emergency department procedural sedation and analgesia in adults. Acad Emerg Med. 2011;18:237–45.

    Article  PubMed  Google Scholar 

  83. David H, Shipp J. Combined ketamine/propofol for emergency department procedural sedation. Ann Emerg Med. 2011;57:435–41.

    Article  PubMed  Google Scholar 

  84. Shah A, Mosdossy G, McLeod S, et al. A blinded, randomized controlled trial to evaluate ketamine-propofol versus ketamine alone for procedural sedation in children. Ann Emerg Med. 2011;57:425–33.

    Article  PubMed  Google Scholar 

  85. Andolfatto G, Abu-Laban RB, Zed PJ, et al. Ketamine-propofol combination (ketofol) versus propofol alone for emergency department procedural sedation and analgesia: a randomized double-blind trial. Ann Emerg Med. 2012;59:504–12.

    Article  PubMed  Google Scholar 

  86. Miner JR, Moore JC, Austad EJ, et al. Randomized, double-blinded clinical trial of propofol, 1:1 propofol/ketamine, and 4:1 propofol/ketamine for deep procedural sedation in the emergency department. Ann Emerg Med. 2015;65:479–88.

    Article  PubMed  Google Scholar 

  87. Green SM, Andolfatto G, Krauss BS. Ketofol for procedural sedation revisited: pro and con. Ann Emerg Med. 2015;65(5):489–91.

    Article  PubMed  Google Scholar 

  88. Olney J, Newcomer JW, Farber NB. NMDA receptor hypofunction model of schizophrenia. J Psychiatr Res. 1999;33:523–33.

    Article  CAS  PubMed  Google Scholar 

  89. Frohlich J, Van Horn JD. Reviewing the ketamine model for schizophrenia. J Psychopharmacol. 2014;28(4):287–302.

    Article  CAS  PubMed  Google Scholar 

  90. Treston G, Bell A, Cardwell R, Fincher G, Chand D, Cashion G. What is the nature of the emergence phenomenon when using intravenous or intramuscular ketamine for paediatric procedural sedation? Emerg Med Australas. 2009;21(4):315–22.

    Article  PubMed  Google Scholar 

  91. Morgan M, Loh L, Singer L, Moore PH. Ketamine as the sole anaesthetic agent for minor surgical procedures. Anaesthesia. 1971;26(2):158–65.

    Article  CAS  PubMed  Google Scholar 

  92. Vlajkovic GP, Sindjelic RP. Emergence delirium in children: many questions, few answers. Anesth Analg. 2007;104:84–91.

    Article  PubMed  Google Scholar 

  93. Sherwin TS, Green SM, Khan A, et al. Does adjunctive midazolam reduce recovery agitation after ketamine sedation for pediatric procedures? A randomized, double-blind, placebo-controlled trial. Ann Emerg Med. 2000;35(3):229–38.

    Article  CAS  PubMed  Google Scholar 

  94. Green SM, Sherwin TS. Incidence and severity of recovery agitation after ketamine sedation in young adults. Am J Emerg Med. 2005;23:142–4.

    Article  PubMed  Google Scholar 

  95. Sener S, Eken C, Schultz CH, et al. Ketamine with and without midazolam for emergency department sedation in adults: a randomized controlled trial. Ann Emerg Med. 2011;57(2):109–114.e2.

    Google Scholar 

  96. Bhatt M, Kennedy R, Osmond MH, Krauss B, et al., Consensus Panel on Sedation Research of Pediatric Emergency Research Canada (PERC) and the Pediatric Emergency Care Applied Research Network (PECARN). Consensus-based recommendations for standardizing terminology and reporting adverse events for emergency department procedural sedation and analgesia in children. Ann Emerg Med. 2009;53:426–35.e4.

    Google Scholar 

  97. Green SM, Yealy DM. Procedural sedation goes Utstein: the Quebec guidelines. Ann Emerg Med. 2009;53:436–8.

    Article  PubMed  Google Scholar 

  98. Hostetler MA, Davis CO. Prospective age-based comparison of behavioral reactions occurring after ketamine sedation in the ED. Am J Emerg Med. 2002;20(5):463–8.

    Article  PubMed  Google Scholar 

  99. Kain ZN, Caldwell-Andrews AA, Maranets I, et al. Preoperative anxiety and emergence delirium and postoperative maladaptive behaviors. Anesth Analg. 2004;99(6):1648–54.

    Article  PubMed  Google Scholar 

  100. Kennedy RM, McAllister JD. Midazolam with ketamine: who benefits? Ann Emerg Med. 2000;35(3):297–9.

    Article  CAS  PubMed  Google Scholar 

  101. Kain ZN, Mayes LC, Wang SM, Hofstadter MB. Postoperative behavioral outcomes in children: effects of sedative premedication. Anesthesiology. 1999;90(3):758–65.

    Article  CAS  PubMed  Google Scholar 

  102. Strayer RJ, Nelson LS. Adverse events associated with ketamine for procedural sedation in adults. Am J Emerg Med. 2008;26:985–1028.

    Article  PubMed  Google Scholar 

  103. Langston WT, Wathen JE, Roback MG, et al. Effect of ondansetron on the incidence of vomiting associated with ketamine sedation in children—a double-blind, randomized placebo controlled trial. Ann Emerg Med. 2008;52(1):30–4.

    Article  PubMed  Google Scholar 

  104. Lee JS, Jeon WC, Park EJ, et al. Adjunctive atropine vs. metoclopramide: can we reduce ketamine-associated vomiting in young children? A prospective, randomized, open, controlled study. Acad Emerg Med. 2012;19:1128–33.

    Article  PubMed  Google Scholar 

  105. Kinder KL, Lehman-Huskamp KL, Gerard JM. Do children with high body mass indices have a higher incidence of emesis when undergoing ketamine sedation? Pediatr Emerg Care. 2012;28:1203–5.

    Article  PubMed  Google Scholar 

  106. Thorp AW, Brown L, Green SM. Ketamine-associated vomiting. Is it dose-related? Pediatr Emerg Care. 2009;25(1):15–8.

    Article  PubMed  Google Scholar 

  107. Treston G. Prolonged pre-procedure fasting time is unnecessary when using titrated intravenous ketamine for paediatric procedural sedation. Emerg Med Australas. 2004;16:145–50.

    Article  PubMed  Google Scholar 

  108. McKee MR, Sharieff GQ, Kanegaye JT, et al. Oral analgesia before pediatric ketamine sedation is not associated with an increased risk of emesis and other adverse events. J Emerg Med. 2008;35(1):23–8.

    Article  PubMed  Google Scholar 

  109. Pena BMG, Krauss B. Adverse events of procedural sedation and analgesia in a pediatric emergency department. Ann Emerg Med. 1999;34:483–90.

    Article  CAS  PubMed  Google Scholar 

  110. Roback MG, Bajaj LB, Wathen J, et al. Preprocedural fasting and adverse events in procedural sedation and analgesia in a pediatric emergency department—are they related? Ann Emerg Med. 2004;44:454–9.

    Article  PubMed  Google Scholar 

  111. Agrawal D, Manzi SF, Gupta R, et al. Preprocedural fasting state and adverse events in children undergoing procedural sedation and analgesia in a pediatric emergency department. Ann Emerg Med. 2003;42:636–46.

    Article  PubMed  Google Scholar 

  112. Corssen G, Little SC, Tavakoli M. Ketamine and epilepsy. Anesth Analg. 1974;53(2):319–35.

    Article  CAS  PubMed  Google Scholar 

  113. Pruss H, Holtkamp M. Ketamine successfully terminates malignant status epilepticus. Epilepsy Res. 2008;82:219–22.

    Article  PubMed  CAS  Google Scholar 

  114. Teodorowicz J, Zimny M. The effect of ketamine in patients with refractory hiccup in the postoperative period. Preliminary report. Anaesth Resusc Intensive Ther. 1975;3(3):271–2.

    CAS  PubMed  Google Scholar 

  115. Shantha TR. Ketamine for the treatment of hiccups during and following anesthesia: a preliminary report. Anesth Analg. 1973;52(5):822–4.

    Article  CAS  PubMed  Google Scholar 

  116. Petrenko AB, Yamakura T, Baba H, Shimoji K. The role of N-Methyl-D-Aspartate (NMDA) receptors in pain: a review. Anesth Analg. 2003;97:1108–16.

    Article  CAS  PubMed  Google Scholar 

  117. Guirimand F, Dupont X, Brasseur L, et al. The effects of ketamine on the temporal summation (wind-up) of the RIII nociceptive flexion reflex and pain in humans. Anesth Analg. 2000;90:408–14.

    CAS  PubMed  Google Scholar 

  118. Angst MS, Clark JD. Opioid-induced hyperalgesia. A qualitative systematic review. Anesthesiology. 2006;104:570–87.

    Article  CAS  PubMed  Google Scholar 

  119. Laulin JP, Maurette P, Corcuff JB, et al. The role of ketamine in preventing fentanyl-induced hyperalgesia and subsequent acute morphine tolerance. Anesth Analg. 2002;94:1263–9.

    Article  CAS  PubMed  Google Scholar 

  120. Menigaux C, Fletcher D, Dupont X. The benefits of intraoperative small-dose ketamine on postoperative pain after anterior cruciate ligament repair. Anesth Analg. 2000;90:129–35.

    Article  CAS  PubMed  Google Scholar 

  121. Menigaux C, Guignard B, Fletcher D, et al. Intraoperative small-dose ketamine enhances analgesia after outpatient knee arthroscopy. Anesth Analg. 2001;93:606–12.

    Article  CAS  PubMed  Google Scholar 

  122. Fu ES, Miguel R, Scharf JE. Preemptive ketamine decreases postoperative narcotic requirements in patients undergoing abdominal surgery. Anesth Anal. 1997;84:1086–90.

    Article  CAS  Google Scholar 

  123. Becke K, Albrecht S, Schmitz B, et al. Intraoperative low dose S-ketamine has no preventive effects on postoperative pain and morphine consumption after major urological surgery in children. Pediatr Anesth. 2005;15:484–90.

    Article  Google Scholar 

  124. Carstensen M, Moller AM. Adding ketamine to morphine for intravenous patient-controlled analgesia for acute postoperative pain: a qualitative review of randomized trials. Br J Anaesth. 2010;104(4):401–6.

    Article  CAS  PubMed  Google Scholar 

  125. Goltser A, Soleyman-Zomalan E, Kresch F, Motov S. Short (low dose) ketamine infusion for managing acute pain in the ED: case-report series. Am J Emerg Med. 2015;33:601.e5–601.e7.

    Google Scholar 

  126. Lester L, Braude DA, Niles C, Crandall CS. Low-dose ketamine for analgesia in the ED: a retrospective case series. Am J Emerg Med. 2010;28:820–7.

    Article  PubMed  Google Scholar 

  127. Galinski M, Dolveck F, Combes X. Management of severe acute pain in emergency settings: ketamine reduces morphine consumption. Am J Emerg Med. 2007;25:385–90.

    Article  PubMed  Google Scholar 

  128. Gurnani A, Sharma PK, Rautela RS, Bhattacharya A. Analgesia for acute musculoskeletal trauma: low-dose subcutaneous infusion of ketamine. Anaesth Intensive Care. 1996;24(1):32–6.

    CAS  PubMed  Google Scholar 

  129. Messenger DW, Murray HE, Dungey PE, et al. Subdissociative dose ketamine versus fentanyl for analgesia during propofol procedural sedation: a randomized clinical trial. Acad Emerg Med. 2008;15:877–86.

    Article  PubMed  Google Scholar 

  130. Svenson JE, Abernathy MK. Ketamine for prehospital use: new look at an old drug. Am J Emerg Med. 2007;25:977–80.

    Article  PubMed  Google Scholar 

  131. Johansson J, Sjoberg J, Nordgren M, et al. Prehospital analgesia using nasal administration of s-ketamine- a case series. Scand J Trauma Resusc Emerg Med. 2013;21:38.

    Article  PubMed  PubMed Central  Google Scholar 

  132. Tran KP, Nguyen Q, Truong XN, et al. A comparison of ketamine and morphine analgesia in prehospital trauma care: a cluster randomized clinical trial in rural Quang Tri Province, Vietnam. Prehosp Emerg Care. 2014;18:257–64.

    Article  PubMed  Google Scholar 

  133. Jennings PA, Cameron P, Bernard S, et al. Morphine and ketamine is superior to morphine alone for out-of-hospital trauma analgesia: a randomized controlled trial. Ann Emerg Med. 2012;59:497–503.

    Article  PubMed  Google Scholar 

  134. Petz LN, Tyner S, Barnard E, et al. Prehospital and en route analgesic use in the combat setting: a prospectively designed, multicenter, observational study. Mil Med. 2015;180(3):14–8.

    Article  PubMed  Google Scholar 

  135. Shackelford SA, Fowler M, Schultz K, et al. Prehospital pain medication use by U.S. forces in Afghanistan. Mil Med. 2015;180(3):304–9.

    Article  PubMed  Google Scholar 

  136. ACEP Excited Delirium Task Force. White paper report on excited delirium syndrome. September 10, 2009. Available at: http://www.academia.edu/1131068/ACEP_Excited_Delirium_White_Paper_-_Contribution_via_CA_Hall_MD_FRCPC. Accessed 22 Feb 2016.

  137. Vilke GM, BeBard ML, Chan TC, et al. Excited delirium syndrome (EXDS): defining based on a review of the literature. J Emerg Med. 2012;43(5):897–905.

    Article  PubMed  Google Scholar 

  138. Green SM, Andolfatto G. Let’s “take ‘em down” with a ketamine blow dart. Ann Emerg Med. 2016;67:588–90.

    Article  PubMed  Google Scholar 

  139. Kowalski JM, Kopec KT, Lavelle J, Osterhoudt K. A novel agent for management of agitated delirium. A case series of ketamine utilization in the pediatric emergency department. Pediatr Emerg Care. 2015 (Epub ahead of print).

    Google Scholar 

  140. Roberts JR, Geeting GK. Intramuscular ketamine for the rapid tranquilization of the uncontrollable, violent, and dangerous adult patient. J Trauma. 2001;51(5):1008–10.

    Article  CAS  PubMed  Google Scholar 

  141. Hick JL, Ho JD. Ketamine chemical restraint to facilitate rescue of a combative “jumper”. Prehosp Emerg Care. 2005;9(1):85–9.

    Article  PubMed  Google Scholar 

  142. Ho JD, Smith SW, Nystrom PC. Successful management of excited delirium syndrome with prehospital ketamine: two case examples. Prehosp Emerg Care. 2013;17:274–9.

    Article  PubMed  Google Scholar 

  143. Burnett AM, Salzman JG, Griffith KR, et al. The emergency department experience with prehospital ketamine: a case series of 13 patients. Prehosp Emerg Care. 2012;16:553–9.

    Article  PubMed  Google Scholar 

  144. Scheppke KA, Braghiroli J, Shalaby M, et al. Prehospital use of im ketamine for sedation of violent and agitated patients. West J Emerg Med. 2014;15(7):736–41.

    Article  PubMed  PubMed Central  Google Scholar 

  145. Isbister GK, Calver LA, Downes MA, Page CB. Ketamine as rescue treatment for difficult-to-sedate severe acute behavioral disturbance in the emergency department. Ann Emerg Med. 2016;67:581–7.

    Article  PubMed  Google Scholar 

  146. Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD, Heninger GR, Bowers Jr MB, Charney DS. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry. 1994;51:199–214.

    Article  CAS  PubMed  Google Scholar 

  147. Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS, Krystal JH. Antidepressant effects of ketamine in depressed patients. Biol Psychiatr. 2000;47:351–4.

    Article  CAS  Google Scholar 

  148. Correll GE, Futter GE. Two case studies of patients with major depressive disorder given low dose (subanesthetic) ketamine infusions. Pain Med. 2006;7:92–5.

    Article  PubMed  Google Scholar 

  149. Zarate CA, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA, Charney DS, Manji HK. A randomized trial of an N-methyl-D-aspartate antagonist in treatment resistant depression. Arch Gen Psychiatry. 2006;63:856–64.

    Article  CAS  PubMed  Google Scholar 

  150. Rasmussen KG, LIneberry TW, Galardy CW, et al. Serial infusion of low-dose ketamine for major depression. J Psychopharm. 2013;27(5):444–50.

    Article  CAS  Google Scholar 

  151. Shiroma PR, Johns B, Kuskowski M, et al. Augmentation of response and remission to serial intravenous subanesthetic ketamine in treatment resistant depression. J Affect Dis. 2014;155:123–9.

    Article  CAS  PubMed  Google Scholar 

  152. Lapidus KA, Levitch CF, Perez AM, et al. A randomized controlled trial of intranasal ketamine in major depressive disorder. Biol Psychiatry. 2014;76(12):970–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  153. Kavalali ET, Monteggia LM. Synaptic mechanisms underlying rapid antidepressant action of ketamine. Am J Psychiatry. 2012;169:1150–6.

    Article  PubMed  Google Scholar 

  154. Naughton M, Clarke G, O’Leary OF, et al. A review of ketamine in affective disorders: current evidence of clinical efficacy, limitation of use and preclinical evidence on proposed mechanism of action. J Affect Disord. 2014;156:24–35.

    Article  CAS  PubMed  Google Scholar 

  155. Salvadore G, Singh JB. Ketamine as a fast acting antidepressant: current knowledge and open questions. CNS Neurosci Ther. 2013;19(6):428–36.

    Article  CAS  PubMed  Google Scholar 

  156. Papolos DF, Teicher MH, Faedda GL, et al. Clinical experience using intranasal ketamine in the treatment of pediatric bipolar disorder/fear of harm phenotype. J Affect Disord. 2013;147:431–6.

    Article  CAS  PubMed  Google Scholar 

  157. Donohgue AC, Roback MG, Cullen KR. Remission from behavioral dysregulation in a child with PTSD after receiving procedural ketamine. Pediatrics. 2015;136(3):e694–6.

    Article  Google Scholar 

  158. Olney JW, Labruyere J, Price MT. Science. 1989;244(4910):1360–2.

    Article  CAS  PubMed  Google Scholar 

  159. Himmelseher S, Pfenninger E, Georgieff M. The effects of ketamine-isomers on neuronal injury and regeneration in rat hippocampal neurons. Anesth Analg. 1996;83:505–12.

    Article  CAS  PubMed  Google Scholar 

  160. Yan J, Jiang H. Dual effects of ketamine: neurotoxicity versus neuroprotection in anesthesia for the developing brain. J Neurosurg Anesthesiol. 2014;26:155–60.

    Article  PubMed  Google Scholar 

  161. Himmelseher S, Duriewx ME. Revising a dogma: ketamine for patients with neurological injury? Anesth Analg. 2005;101:524–34.

    Article  CAS  PubMed  Google Scholar 

  162. Green SM, Coté CJ. Ketamine and neurotoxicity: clinical perspectives and implications for emergency medicine. Ann Emerg Med. 2009;54:181–90.

    Article  PubMed  Google Scholar 

  163. Jevtovic-Todorovic V, Absalom AR, Blomgren K, et al. Anaesthetic neurotoxicity and neuroplasticity: an expert group report and statement based on the BJA Salzburg Seminar. Br J Anaesth. 2013;111:143–51.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  164. Rappaport BA, Suresh S, Hertz S, et al. Anesthetic neurotoxicity – clinical implication of animal models. N Engl J Med. 2015;372(9):796–7.

    Article  CAS  PubMed  Google Scholar 

  165. Yan J, Li Y, Zhang Y, Lu Y, Jiang H. Repeated exposure to anesthetic ketamine can negatively impact neurodevelopment in infants: a prospective preliminary clinical study. J Child Neurol. 2014;29(10):1333–8.

    Article  PubMed  Google Scholar 

  166. Loepke AW, Soriano SG. An assessment of the effects of general anesthetics on developing brain structure and neurocognitive function. Anesth Analg. 2008;106:1681–707.

    Article  PubMed  Google Scholar 

  167. Hayashi H, et al. Repeated administration of ketamine may lead to neuronal degeneration in the developing rat brain. Paediatr Anaesth. 2002;12:770–4.

    Article  PubMed  Google Scholar 

  168. SmartTots. Consensus Statement Supplement 11/2015. Available at: http://smarttots.org/consensus-statement-supplement/. Accessed 19 Feb 2016.

  169. Jevtovic-Todorovic V, Wazniak DF, Benshoff ND, et al. A comparative evaluation of neurotoxic properties of ketamine and nitrous oxide. Brain Res. 2001;895:264–7.

    Article  CAS  PubMed  Google Scholar 

  170. Mellon RD, Simone AF, Rappaport BA. Use of anesthetic agents in neonates and young children. Anesth Analg. 2007;104:509–20.

    Article  CAS  PubMed  Google Scholar 

  171. Newcomer JW, Farber NB, Jevtovic-Todorovic V, et al. Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis. Neuropsychopharmacology. 1999;20(2):106–18.

    Article  CAS  PubMed  Google Scholar 

  172. Zou X, Patterson TA, Bivine RL, et al. Prolonged exposure to ketamine increases neurodegeneration in the developing monkey brain. Int J Dev Neuosci. 2009;27:727–31.

    Article  CAS  Google Scholar 

  173. Schifano F, Corkery J, Oyefeso A, et al. Trapped in the “K-hole”: overview of deaths associated with ketamine misuse in the UK (1993–2006). J Clin Psychopharmacol. 2008;28:114–6.

    Article  PubMed  Google Scholar 

  174. Wang JW, Kivovich V, Gordon L. Ketamine abuse syndrome. Hepatobiliary and urinary pathology among adolescents in Flushing, NY. Pediatr Emerg Care. 2015 (Epub ahead of print).

    Google Scholar 

  175. Muetzelfeldt L, Kamboj SK, Rees H, et al. Journey through the K-hole: phenomenological aspects of ketamine use. Drug Alcohol Depend. 2008;95(3):219–29.

    Article  CAS  PubMed  Google Scholar 

  176. Morgan CJ, Riccelli M, Maitland CH, Curran HV. Long-term effects of ketamine: evidence for a persisting impairment of source memory in recreational users. Drug Alcohol Depend. 2004;75(3):301–8.

    Article  CAS  PubMed  Google Scholar 

  177. Gill JR, Stajic M. Ketamine in non-hospital and hospital deaths in New York City. J Forensic Sci. 2000;45(3):655–8.

    Article  CAS  PubMed  Google Scholar 

  178. Lankenau SE, Clatts MC. Drug injection practices among high-risk youths: the first shot of ketamine. J Urban Health. 2004;81(2):232–48.

    Article  PubMed  PubMed Central  Google Scholar 

  179. Dillon P, Copeland J, Jansen K. Patterns of use and harms associated with on-medical ketamine use. Drug Alcohol Depend. 2003;69:23–8.

    Article  PubMed  Google Scholar 

  180. WHO. WHO model lists of essential medicines. 2015 [updated 2015; cited February 11, 2016]; Available from: http://www.who.int/medicines/publications/essentialmedicines/en/.

Download references

Acknowledgments

I wish to acknowledge Dr. Keira Mason for her unwavering support of the multidisciplinary approach to sedation for children outside the operating room and Drs. Bo Kennedy and Steve Green for being my ketamine mentors and colleagues.

Author information

Authors and Affiliations

  1. Department of Pediatrics & Emergency Medicine, University of Minnesota Medical School and University of Minnesota Masonic Children’s Hospital, M653 East Building, Minneapolis, MN, 55454, USA

    Mark G. Roback M.D.

Authors
  1. Mark G. Roback M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mark G. Roback M.D. .

Editor information

Editors and Affiliations

  1. Department of Anesthesiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

    Anthony R. Absalom

  2. Department of Anesthesia, Harvard Medical School, Department of Anesthesiology, Perioperative and Pain Medicine, Boston Children’s Hospital, Boston, Massachusetts, USA

    Keira P. Mason

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Roback, M.G. (2017). Clinical Effects and Applications of Ketamine. In: Absalom, A., Mason, K. (eds) Total Intravenous Anesthesia and Target Controlled Infusions. Springer, Cham. https://doi.org/10.1007/978-3-319-47609-4_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-47609-4_14

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-47607-0

  • Online ISBN: 978-3-319-47609-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation